101: Biotechnology and Healthcare: A New Dawn...

Emerging Markets, once the darling of the asset allocators world, have found themselves increasingly discarded by those same allocators. Such became the re-allocation away from them and the magnetism of the US & its technology companies, that as recently as the end of 2024, Emerg ...  Show more

As Mike Milken said on this podcast, “the greatest achievement of humankind in the 20th century, was the doubling of life expectancy.” If living longer seems a powerful goal, the caveat would be only if it goes hand in hand with being healthy whilst being older, AND in not runnin ...  Show more

Biotechnology is the use of biology in the production of new products, services, and organisms with the aim of improving human health and society. In 2024, the global biotech market was worth $1.68 trillion. By application, the health segment was responsible for just over half of ...  Show more

In this episode, Peter and Naveen discuss the future of healthcare, how AI will revolutionize our health, and how to raise Moonshot kids.    Recorded on July 22nd, 2024 Views are my own thoughts, not Financial, Medical, or Legal Advice. 05:04 | The Cost of Chronic Diseases 38 ...  Show more

In this episode, Ray and Peter discuss the changing world order, China vs. the USA, and Ray’s thoughts on the future of the US. Recorded on Feb 3rd, 2025 Views are my own thoughts; not Financial, Medical, or Legal Advice. Ray Dalio is a renowned investor, hedge fund manager, an ...  Show more

Fall means it's time for your annual flu and Covid shots! So, this week on The CMO Podcast, Jim welcomes Kate Cronin, the Chief Brand Officer for Moderna, the 14-year-old pioneering biotech company. Moderna achieved nearly instant awareness and fame in 2020, when it received ...